Decathlon Capital Partners
600 Hansen Way, Palo Alto, CA, 94304, United States
Overview
Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized revenue-based financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding.
- Total investments
- 2
- Lead investments
- 2
- Investments · 12mo
- 0
- Active investors
- 3
Sector focus
- Financial Services
Investment portfolio
- Made Modern
Led · Equity · Feb 2018
Made Modern LLC is a New York–based developer of products and media aimed at fostering creativity in children ages 4 through 11. Its flagship brand, Kid Made Modern, offers gender-neutral, sustainably sourced arts-and-crafts, clothing, back-to-school and home goods that encourage children to express their creativity. Launched in 2010 by designer Todd Oldham and led by CEO Brian Richards, the company has created more than 1,000 products and media. In February 2018 Made Modern completed a $3M financing transaction with Decathlon Capital Partners. The investment will enable Kid Made Modern to increase inventory, expand distribution, invest in e-commerce opportunities and make key personnel moves to reach a larger audience. The financing is intended to support the brand's growth and expanded market reach.
- SonaCare Medical
Led · Equity · Aug 2017
SonaCare Medical is a Charlotte, NC–based developer and manufacturer of high-intensity focused ultrasound (HIFU) technologies focused on minimally invasive prostate tissue ablation. Founded in 2004 by chairman Stephen Puckett and led by CEO Mark Carol, the company operates subsidiary Focus Surgery, Inc. Its product portfolio includes the Sonablate®, which has 510(k) clearance in the U.S.; the Sonablate® 500, which holds CE marking and regulatory authorization in more than 50 countries; and the Sonatherm® laparoscopic HIFU system, which has 510(k) clearance, CE marking, and authorization in more than 30 countries. The company received $3M in growth financing from Palo Alto–based Decathlon Capital Partners. The capital will fund sales initiatives following the Medicare C-Code approval that went into effect on July 1.